Cbl-b-IN-13
Product Specifications
UNSPSC Description
Cbl-b-IN-13 (Example 520) is a Cbl-b inhibitor with an IC50 of [1].
Target Antigen
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cbl-b-in-13.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC(CN3CCC4(CC4)C3)=CC(C(F)(F)F)=C2CN1C5=CC=CC(C6(CC7=NN=CN7C)COC6)=C5
Molecular Weight
537.58
References & Citations
[1]Paul A. Barsanti, et al. Inhibitors of cbl-b and methods of use thereof. Patent WO2019148005A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156769/Cbl-b-IN-13-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156769/
Clinical Information
No Development Reported
CAS Number
2368841-85-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
